Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Marathon US hearings to decide fate of COVID shots for tots

Next week brings a marathon of hearings as the U.S. decides whether to open COVID-19 vaccinations to kids under 5

The Independent UK

We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit

A group of pharmaceutical stocks are climbing as they pivot their diabetes drugs to help treat obesity. A potential multibillion-dollar market beckons them.

Investors Business Daily

Forget Tech Titans Like Apple, Nvidia — Top Funds Bet On These Stocks

While Apple, Nvidia, Microsoft and GOOGL stock have gone MIA, the best mutual funds bet big on medical, defense and oil stocks.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Mayo Clinic Minute: What to expect with COVID-19 vaccinations for youngest kids

The Food and Drug Administration (FDA) could grant emergency use authorization of a COVID-19 vaccination for the youngest kids later this month. Pfizer asked the agency to review data and authorize its COVID-19 vaccine for children ages 6 months to 5 years.

Tribune News Service

Malcolm Roberts says a rule change at the WHO 'would have decimated' Australia's sovereignty. Is he correct?

The One Nation senator has continued to push the baseless claim that Australia could be forced to adopt restrictive health measures by the World Health Organization.

ABC News

Novavax Dive Continues As FDA Reviews New Covid Shot Information

Three days after the FDA's advisors recommended Novavax's Covid shot, the agency had yet to make a move, and NVAX stock toppled.

Investors Business Daily

US Schedules Covid-19 Vaccines For Children Below Five Years

The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports. The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious. The vaccinations could begin…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Pfizer And 3 Other Stocks Insiders Are Selling

US stock futures traded mixed this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Paxlovid and rebound Covid-19 infections: What you need to know

Some people who take Pfizer's oral antiviral for Covid-19 report testing negative after treatment only to test positive again days later.

Inverse

White House expects COVID vaccine orders for children under 5 to pick up

Pre-orders of vaccines for children under age five have been slow, but Biden administration senior officials say they are not alarmed and expect the pace to pick up after federal approvals later this month.

Reuters

Officials: Millions of COVID-19 shots ordered for youngest

White House officials say orders have been coming in for COVID-19 vaccine doses for small children

The Independent UK

New vaccine may be option for troops with religious concerns

A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other coronavirus vaccines for religious reasons

The Independent UK

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker

Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide strong

Benzinga

Adolescents aged 12 to 15 at risk of severe disease able to get COVID-19 booster after government accepts latest ATAGI advice

Australian teenagers aged 12-15 who are at risk of severe disease will be able to receive a COVID-19 booster shot from as early as next week.

ABC News

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

COVID antivirals: Who is eligible for Paxlovid and molnupiravir and how can I get them?

Confusion and lack of awareness around who qualifies for COVID antivirals — and who doesn't — may be why some eligible patients aren't getting the medications.

Benzinga

What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US

After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.

Tribune News Service

Can new COVID-19 vaccine win over the anti-vaxxers?

With three COVID-19 vaccines already authorized by the U.S. Food and Drug Administration, Americans have easy access to plenty of shots.

The Independent UK

FDA advisers back Novavax COVID-19 shots as new US option

A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

MTG falls for fake Twitter account

The fake account misleadingly tweeted that Pfizer's vaccine has caused widespread miscarriages

Investors Business Daily

Novavax Stock Jumps After FDA Advisors Endorse Its Covid Shot

An FDA panel voted nearly unanimously in favor of Novavax's Covid shot on Tuesday. After yo-yoing Wednesday, NVAX stock settled up.

Benzinga

Morning Brief: Top Financial Stories Dominating on Tuesday, June 7

Reuters

Benzinga

Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment

Pfizer, Inc. (NYSE: PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.

Salon

Novavax's new shot may sway anti-vaxxers

Experts hope the new COVID vaccine, which uses older biotechnology, could help the unvaccinated come around

Bangkok Post

Numbers ploy

Re: "Toxically un-Thai," (letters, June 1).

The Philadelphia Inquirer

Kids under 5 should soon have access to COVID vaccines, but many parents are likely to say, I don’t feel comfortable'

PHILADELPHIA — Zoli’s parents plan to get their 4-year-old son vaccinated against COVID-19 as soon as shots for young children could finally become available later this month.

1 … 47 48 49 50

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.